| Literature DB >> 28139690 |
Lik-Chin Ten1, Yoon-Ming Chin1, Mei-Chee Tai1, Edmund Fui-Min Chin2, Yat-Yuen Lim1, Sujatha Suthandiram3, Kian-Meng Chang4, Tee-Chuan Ong4, Ping-Chong Bee2, Zahurin Mohamed3, Gin-Gin Gan2, Ching-Ching Ng1.
Abstract
Large consortia efforts and genome-wide association studies (GWASs) have linked a number of genetic variants within the 6p21 chromosomal region to non-Hodgkin lymphoma (NHL). Complementing these efforts, we genotyped previously reported SNPs in the human leukocyte antigen (HLA) class I (rs6457327) and class II (rs9271100, rs2647012 and rs10484561) regions in a total of 1,145 subjects (567 NHL cases and 578 healthy controls) from two major ethnic groups in Malaysia, the Malays and the Chinese. We identified a NHL-associated (PNHL_add = 0.0008; ORNHL_add = 0.54; 95% CI = 0.37-0.77) and B-cell associated (PBcell_add = 0.0007; ORBcell_add = 0.51; 95% CI = 0.35-0.76) SNP rs2647012 in the Malaysian Malays. In silico cis-eQTL analysis of rs2647012 suggests potential regulatory function of nearby HLA class II molecules. Minor allele rs2647012-T is linked to higher expression of HLA-DQB1, rendering a protective effect to NHL risk. Our findings suggest that the HLA class II region plays an important role in NHL etiology.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28139690 PMCID: PMC5282517 DOI: 10.1038/srep41400
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographics of study subjects.
| Malay (n = 612) | Chinese (n = 533) | Total (n = 1,145) | ||||
|---|---|---|---|---|---|---|
| Case (%) | Control (%) | Case (%) | Control (%) | Case (%) | Control (%) | |
| 166 (54.6%) | 170 (55.2%) | 147 (55.9%) | 156 (57.8%) | 313 (55.2%) | 326 (56.4%) | |
| 138 (45.4%) | 138 (44.8%) | 116 (44.1%) | 114 (42.2%) | 254 (44.8%) | 252 (43.6%) | |
| 51.8 (±14.7) | 39.7 (±10.0) | 57.1 (±14.4) | 49.1 (±12.1) | 54.6 (±14.7) | 44.2 (±14.1) | |
| 18–91 | 19–85 | 18–87 | 18–84 | 18–91 | 18–85 | |
| 268 (88.2%) | — | 228 (86.7%) | — | 496 (87.5%) | — | |
| DLBCL | 173 (56.9%) | — | 129 (49.0%) | — | 302 (53.3%) | — |
| FL | 38 (12.5%) | — | 45 (17.1%) | — | 83 (14.6%) | — |
| Others | 57 (18.8%) | — | 54 (20.5%) | — | 111 (19.6%) | — |
| 36 (11.8%) | — | 35 (13.3%) | — | 71 (12.5%) | — | |
| 304 (100%) | 308 (100%) | 263 (100%) | 270 (100%) | 567 (100%) | 578 (100%) | |
*Abbreviations: NHL, non-Hodgkin’s lymphoma; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma.
aAge at interviewed for cases and controls- Mean (Standard deviation).
bOthers: Other types of B-cell NHL except DLBCL and FL.
cT-cell NHL: Included all the subtypes of T-cell NHL.
Association of rs2647012 with NHL in Malay study subjects according to different age groups.
| NHL Type | SNP | Position | Nearby genes | Subjects | Sample size (Case/Ctrl) | MAF (Case/Ctrl) | OR (95% CI) | Genetic model | Power | |
|---|---|---|---|---|---|---|---|---|---|---|
| All NHL | rs2647012 | Chr 6: | 30 kb 5′ of | ALL | 304/308 | 0.11/0.18 | 0.54 (0.37–0.77) | 0.0008 | Additive | 64.1% |
| C > T | 32,696,681 | Case & control 18–55 y/o | 170/195 | 0.11/0.19 | 0.55 (0.36–0.84) | 0.005408 | Additive | 30.8% | ||
| Smedby | Control > 40 y/o | 304/139 | 0.11/0.18 | 0.56 (0.38–0.84) | 0.0045 | Additive | 30.0% | |||
| B-cell NHL | rs2647012 | Chr 6: | 30 kb 5′ of | Additive | ||||||
| C > T | 32,696,681 | Case & control 18–55 y/o | 145/195 | 0.11/0.19 | 0.53 (0.34–0.83) | 0.006009 | Additive | 31.2% | ||
| Smedby | Control > 40 years | 268/139 | 0.11/0.18 | 0.54 (0.36–0.82) | 0.003657 | Additive | 33.0% |
+rs2647012 shows no deviation from HWE (PNHL_HWE = 0.2375; PBcell_HWE = 0.2375).
*SNPs showing P < 0.00083 is considered significantly associated and highlighted in black. Bonferroni threshold includes correcting for 4 independent SNPs across 3 sample groups and 5 NHL types.
Demographics of Malay study subjects according to different age groups.
| Age group | Age range | NHL Type | Average age (SD) | Median age | Case | Control |
|---|---|---|---|---|---|---|
| Case = 18–55;Ctrls = 19–55 | All NHL | Case = 41.6 (±10.5);Ctrls = 39.4 (±8.9) | Case = 45;Ctrls = 39 | Male = 86;Female = 84;Total = 170 | Male = 100;Female = 95;Total = 195 | |
| B-cell NHL | Case = 42 (±10.4);Ctrls = 39.4 (±8.9) | Case = 45;Ctrls = 39 | Male = 75;Female = 70;Total = 145 | Male = 100;Female = 95;Total = 195 | ||
| Case = 18–91;Ctrls = 40–95 | All NHL | Case = 51.8 (±14.7);Ctrls = 48.3 (±7.7) | Case = 54;Ctrls = 47 | Male = 166;Female = 138;Total = 304 | Male = 86;Female = 53;Total = 139 | |
| B-cell NHL | Case = 52.6 (±14.5);Ctrls = 48.3 (±7.7) | Case = 54.5;Ctrls = 47 | Male = 147;Female = 121;Total = 268 | Male = 86;Female = 53;Total = 139 |
*Abbreviations: NHL, non-Hodgkin’s lymphoma; Ctrls, controls.
aAge at interviewed for cases and controls- Mean (Standard deviation).
Figure 1cis-eQTL analysis of NHL associated SNPs in EBV-transformed lymphocytes.
Box-and-whisker plots showing correlation of rs2647012 C/T with expression levels of (a) HLA-DQB1-AS1 (b) HLA-DQA2 (c) HLA-DQB1 (d) HLA-DRB6.